Search Within

Hematology-Oncology Fellows

Formats
  1. Meeting Abstract (636)
  2. Journal Article (505)
  3. Review (142)
  4. Editorial (64)
  5. Research Letter (50)
  6. Correspondence (14)
  7. Guidelines (6)
  8. Book Section (3)
  9. Conference Paper (2)
  10. Miscellaneous (2)
Groups
  1. Department of Medicine (1160)
  2. Graduate Medical Education (1117)
  3. GME, Medicine (1093)
  4. Hematologic Malignancies, Division of (748)
  5. Weinberg Fellows (657)
  6. Solid Tumor Oncology Division (614)

More Groups

People
  1. Jan Bewersdorf (102)
  2. Gunjan Shah (93)
  3. Maria Palomba (93)
  4. Zachary Epstein-Peterson (93)
  5. Gilles Salles (88)
  6. Michael Scordo (87)

More People

Years
  1. 2025 (160)
  2. 2024 (357)
  3. 2023 (296)
  4. 2022 (222)
  5. 2021 (159)
  6. 2020 (114)

More Years

Publications
  1. Blood (288)
  2. Journal of Clinical Oncology (219)
  3. Clinical Cancer Research (38)
  4. Annals of Oncology (35)
  5. Cancer Research (35)
  6. Journal of Thoracic Oncology (30)

More Publications

Publishers
  1. American Society of Hematology (323)
  2. American Society of Clinical Oncology (251)
  3. Elsevier Inc. (142)
  4. Nature Publishing Group (107)
  5. American Association for Cancer Research (104)
  6. Oxford University Press (61)

More Publishers

Results (1424)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Diverse alterations associated with resistance to KRAS(G12C) inhibition
    Journal Article

    Zhao, Y.; Murciano-Goroff, Y. R.; Xue, J. Y.; Ang, A.; Lucas, J.; Mai, T. T.; Da Cruz Paula, A. F.; Saiki, A. Y.; Mohn, D.; Achanta, P.; more...
    Nature (2021)

    Fulltext@MSK | Save
  • Does the conventional cytogenetic risk profile still matter for prediction of venetoclax based treatment outcomes in AML?
    Editorial

    Bewersdorf, J. P.; Stone, R. M.; Tallman, M. S.; Stahl, M.
    Leukemia and Lymphoma (2021)

    Fulltext@MSK | Save
  • Venetoclax-based combinations in AML and high-risk MDS prior to and following allogeneic hematopoietic cell transplant
    Journal Article

    Bewersdorf, J. P.; Derkach, A.; Gowda, L.; Menghrajani, K.; DeWolf, S.; Ruiz, J. D.; Ponce, D. M.; Shaffer, B. C.; Tamari, R.; Young, J. W.; more...
    Leukemia and Lymphoma (2021)

    Fulltext@MSK | Save
  • Hypomethylating agents and FLT3 inhibitors as maintenance treatment for acute myeloid leukemia and myelodysplastic syndrome after allogeneic hematopoietic stem cell transplantation - A systematic review and meta-analysis
    Review

    Bewersdorf, J. P.; Allen, C.; Mirza, A. S.; Grimshaw, A. A.; Giri, S.; Podoltsev, N. A.; Gowda, L.; Cho, C.; Tallman, M. S.; Zeidan, A. M.; more...
    Transplantation and Cellular Therapy (2021)

    Fulltext@MSK | Save
  • Erlotinib and trametinib in patients with EGFR-mutant lung adenocarcinoma and acquired resistance to a prior tyrosine kinase inhibitor
    Journal Article

    Luo, J.; Makhnin, A.; Tobi, Y.; Ahn, L.; Hayes, S. A.; Iqbal, A.; Ng, K.; Arcila, M. E.; Riely, G. J.; Kris, M. G.; more...
    JCO Precision Oncology (2021)

    Fulltext@MSK | Save
  • Current knowledge in genetics, molecular diagnostic tools, and treatments for mantle cell lymphomas
    Review

    Sethi, S.; Epstein-Peterson, Z.; Kumar, A.; Ho, C.
    Frontiers in Oncology (2021)

    Fulltext@MSK | Save
  • Bridging chemotherapy prior to CD19-specific CAR T-cell therapy in children/young adults with relapsed/refractory acute lymphoblastic leukemia
    Meeting Abstract

    Shahid, S.; Ramaswamy, K.; Flynn, J.; Mauguen, A.; Boelens, J. J.; Forlenza, C.; Kernan, N.; Shukla, N.; Steinherz, P.; Sulis, M. L.; more...
    Pediatric Blood and Cancer (2021)

    Fulltext@MSK | Save
  • Multi-omic characterization of lung tumors implicates AKT and MYC signaling in adenocarcinoma to squamous cell transdifferentiation
    Meeting Abstract

    Quintanal-Villalonga, A.; Taniguchi, H.; Zhan, Y.; Hasan, M.; Chavan, S.; Uddin, F.; Allaj, V.; Manoj, P.; Shah, N.; Chan, J.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • CRISPR screen reveals XPO1 as a therapeutic target strongly sensitizing to first and second line therapy in small cell lung cancer
    Meeting Abstract

    Quintanal-Villalonga, A.; Taniguchi, H.; Hao, Y.; Chow, A.; Zhan, Y.; Chavan, S.; Uddin, F.; Allaj, V.; Manoj, P.; Shah, N.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save
  • Signatures of plasticity and immunosuppression in a single-cell atlas of human small cell lung cancer
    Meeting Abstract

    Chan, J.; Quintanal-Villalonga, A.; Gao, V.; Xie, Y.; Allaj, V.; Chaudhary, O.; Masilionis, I.; Egger, J.; Chow, A.; Walle, T.; more...
    Journal of Thoracic Oncology (2021)

    Fulltext@MSK | Save